These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8089024)

  • 1. Prescription drug utilization review in the private sector.
    Kralewski J; Wertheimer A; Ratner E
    Health Care Manage Rev; 1994; 19(2):62-71. PubMed ID: 8089024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug utilization review using a Medicaid claims database.
    Sena MM; Pashko S
    Clin Ther; 1993; 15(5):900-4. PubMed ID: 8269457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of inappropriate drug prescribing by computerized, retrospective DUR screening in Korea.
    Yeom JH; Park JS; Oh OH; Shin HT; Oh JM
    Ann Pharmacother; 2005 Nov; 39(11):1918-23. PubMed ID: 16219902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ineffectiveness of retrospective drug utilization review.
    Hennessy S; Strom BL
    LDI Issue Brief; 2003 Sep; 9(1):1-4. PubMed ID: 14577443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.
    Sarma S; Basu K; Gupta A
    Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing prescription drug costs.
    Sica JM
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Watching the monitors: "PAID" prescriptions, fiscal intermediaries and drug-utilization review.
    Morgan JP
    N Engl J Med; 1977 Feb; 296(5):251-6. PubMed ID: 318733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DUR by pharmacists--lessons learned for MTMS.
    Perrin PB
    Consult Pharm; 2006 Apr; 21(4):257; author reply 257. PubMed ID: 16676476
    [No Abstract]   [Full Text] [Related]  

  • 10. A successful field-based pharmacy program.
    Miller W
    Med Interface; 1995 Feb; 8(2):71-4, 77. PubMed ID: 10140634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health plans' strategies for managing outpatient specialty pharmaceuticals.
    Mullins CD; Lavallee DC; Pradel FG; DeVries AR; Caputo N
    Health Aff (Millwood); 2006; 25(5):1332-9. PubMed ID: 16966730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid program; Drug Use Review program and electronic claims management system for outpatient drug claims--HCFA. Interim final rule with comment period.
    Fed Regist; 1992 Nov; 57(212):49397-412. PubMed ID: 10122482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Trial" prescriptions to reduce drug wastage: results from Canadian programs and a community demonstration project.
    Paterson JM; Anderson GM
    Am J Manag Care; 2002 Feb; 8(2):151-8. PubMed ID: 11853203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug utilization review: mechanisms to improve its effectiveness and broaden its scope. The U.S. Pharmacopeia Drug Utilization Review Advisory Panel.
    J Am Pharm Assoc (Wash); 2000; 40(4):538-45. PubMed ID: 10932464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid program; drug use review program and electronic claims management system for outpatient drug claims--HCFA. Final rule.
    Fed Regist; 1994 Sep; 59(184):48811-25. PubMed ID: 10137645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and cost of drugs in a pharmaceutically decentralized health maintenance organization.
    Hardigan WD; Slywka GW; Eng HJ
    Contemp Pharm Pract; 1980; 3(1):23-30. PubMed ID: 10245109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.